Venus Medtech (Hangzhou), Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-436.00
-798.00
-798.00
-1,328.00
-440.00
-209.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-80.00
129.00
93.00
-163.00
-176.00
-155.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-369.00
-195.00
-484.00
-887.00
-526.00
-265.00
Cash Flow from Investing Activities
391.00
-30.00
-406.00
-1,249.00
-753.00
-312.00
Cash Flow from Financing Activities
-180.00
-504.00
-154.00
783.00
1,620.00
1,020.00
Net Cash Inflow / Outflow
-156.00
-722.00
-1,017.00
-1,248.00
297.00
333.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
7.00
28.00
105.00
-41.00
-109.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Venus Medtech (Hangzhou), Inc.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-436.826492306401
256.750062784874
-692.00
-270.14%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-80.6603411741246
72.502556379549
-152.00
-211.25%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-369.086078047695
419.802728956168
-788.00
-187.92%
Cash Flow from Investing Activities
391.997718777581
-51.818526653127
442.00
856.48%
Cash Flow from Financing Activities
-180.933202984397
-187.748347846018
7.00
3.63%
Net Cash Inflow / Outflow
-156.246197496638
175.093044633056
-331.00
-189.24%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.77536475787294
-5.14280982396669
6.00
134.52%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -89.06% vs 59.72% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-369.09
-195.22
-89.06%






